The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
An HMG-CoA Reductase Inhibitor, Cerivastatin, Suppresses Growth of Macrophages Expressing Matrix Metalloproteinases and Tissue Factor In Vivo and In Vitro
Open accessAbstract
Background —Unstable atherosclerotic plaques that cause acute coronary events usually contain abundant macrophages expressing matrix metalloproteinases (MMPs) and tissue factor (TF), molecules that probably contribute to plaque rupture and subsequent thrombus formation. Lipid lowering with HMG-CoA reductase inhibitors reduces acute coronary events. Methods and Results —To test whether lipid lowering with an HMG-CoA reductase inhibitor retards macrophage accumulation in rabbit atheroma, we administered cerivastatin to immature Watanabe heritable hyperlipidemic rabbits (cerivastatin group, n=10, cerivastatin 0.6 mg · kg −1 · d −1 ; control group, n=9, saline 0.6 mL · kg −1 · d −1 ) for 32 weeks and measured macrophage accumulation and expression of MMPs and TF. Serum cholesterol levels after 32 weeks were 809±40 mg/dL (control group) and 481±24 mg/dL (treated group). Cerivastatin diminished accumulation of macrophages in aortic atheroma. Macrophage expression of MMP-1, MMP-3, MMP-9, and TF also decreased with cerivastatin treatment. Cerivastatin reduced the number of macrophages expressing histone mRNA (a sensitive marker of cell proliferation) detected by in situ hybridization but did not alter macrophages bearing a marker of death (TUNEL staining). Cerivastatin treatment (≥0.01 μmol/L) also reduced growth, proteolytic activity due to MMP-9, and TF expression in cultured human monocyte/macrophages. Conclusions —These results suggest that lipid lowering with HMG-CoA reductase inhibitors alters plaque biology by reducing proliferation and activation of macrophages, prominent sources of molecules responsible for plaque instability and thrombogenicity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Falk, E., Shah, P. K., & Fuster, V. (1995) · Circulation · doi:10.1161/01.cir.92.3.657 · Cited by 3,536
Galis, Z. S., Sukhova, G. K., Lark, M. W., & Libby, P. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117619 · Cited by 2,539
Self-citationMolecular Bases of the Acute Coronary Syndromes
Libby, P. (1995) · Circulation · doi:10.1161/01.cir.91.11.2844 · Cited by 2,028
Self-citationLocalization of tissue factor in the normal vessel wall and in the atherosclerotic plaque.
Wilcox, J. N., Smith, K. M., Schwartz, S. M., & Gordon, D. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.8.2839 · Cited by 1,214
Macrophage infiltration in acute coronary syndromes. Implications for plaque rupture.
Moreno, P. R., Falk, E., Palacios, I. F., Newell, J. B., Fuster, V, & Fallon, J. T. (1994) · Circulation · doi:10.1161/01.cir.90.2.775 · Cited by 1,108
Metcalf, D. (1989) · Nature · doi:10.1038/339027a0 · Cited by 1,023
Brown, B. G., Zhao, X. Q., Sacco, D. E., & Albers, J. J. (1993) · Circulation · doi:10.1161/01.cir.87.6.1781 · Cited by 821
Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization.
Henney, A. M., Wakeley, P. R., Davies, M. J., Foster, K., Hembry, R., Murphy, G., & Humphries, S. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.18.8154 · Cited by 590
The evolving role of statins in the management of atherosclerosis
Vaughan, C. J., Gotto, A. M., & Basson, C. T. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00525-2 · Cited by 574
Aikawa, M., Rabkin, E., Okada, Y., Voglic, S. J., Clinton, S. K., Brinckerhoff, C. E., Sukhova, G. K., & Libby, P. (1998) · Circulation · doi:10.1161/01.cir.97.24.2433 · Cited by 555
Self-citation
Cited by
Inflammation in atherosclerosis
Libby, P. (2002) · Nature · doi:10.1038/nature01323 · Cited by 8,315
Self-citationInflammation and Atherosclerosis
Libby, P., Ridker, P. M., & Maseri, A. (2002) · Circulation · doi:10.1161/hc0902.104353 · Cited by 7,724
Self-citationInflammation in Atherosclerosis
Libby, P. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.179705 · Cited by 3,736
Self-citationPLEIOTROPIC EFFECTS OF STATINS
Liao, J. K., & Laufs, U. (2005) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.095748 · Cited by 1,994
Albert, M. A., Danielson, E., Rifai, N., Ridker, P. M., & for the PRINCE Investigators (2001) · JAMA · doi:10.1001/jama.286.1.64 · Cited by 1,641
Current Concepts of the Pathogenesis of the Acute Coronary Syndromes
Libby, P. (2001) · Circulation · doi:10.1161/01.cir.104.3.365 · Cited by 1,558
Self-citationPleiotropic Effects of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors
Takemoto, M., & Liao, J. K. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq1101.098486 · Cited by 1,272
Mechanisms of Acute Coronary Syndromes and Their Implications for Therapy
Libby, P. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1216063 · Cited by 1,262
Self-citationLocal proliferation dominates lesional macrophage accumulation in atherosclerosis
Robbins, C. S., Hilgendorf, I., Weber, G. F., Theurl, I., Iwamoto, Y., Figueiredo, J.-L., Gorbatov, R., Sukhova, G. K., Gerhardt, L. M. S., Smyth, D., et al. (2013) · Nature Medicine · doi:10.1038/nm.3258 · Cited by 1,041
Self-citationAnti-Inflammatory Effects of Statins: Clinical Evidence and Basic Mechanisms
Jain, M. K., & Ridker, P. M. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1901 · Cited by 915
Research Progress on the Relationship between Atherosclerosis and Inflammation
Zhu, Y., Xian, X., Wang, Z., Bi, Y., Chen, Q., Han, X., Tang, D., & Chen, R. (2018) · Biomolecules · doi:10.3390/biom8030080 · Cited by 872
Newby, A. C. (2005) · Physiological Reviews · doi:10.1152/physrev.00048.2003 · Cited by 817
Inflammation in Atherosclerosis: Transition From Theory to Practice
Libby, P., Okamoto, Y., Rocha, V. Z., & Folco, E. (2010) · Circulation Journal · doi:10.1253/circj.cj-09-0706 · Cited by 799
Self-citationStatins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis
Nicholls, S. J., Tuzcu, E. M., Sipahi, I., Grasso, A. W., Schoenhagen, P., Hu, T., Wolski, K., Crowe, T., Desai, M. Y., Hazen, S. L., et al. (2007) · JAMA · doi:10.1001/jama.297.5.499 · Cited by 724
Aikawa, E., Nahrendorf, M., Figueiredo, J.-L., Swirski, F. K., Shtatland, T., Kohler, R. H., Jaffer, F. A., Aikawa, M., & Weissleder, R. (2007) · Circulation · doi:10.1161/circulationaha.107.732867 · Cited by 698
Self-citationStabilization of atherosclerotic plaques: New mechanisms and clinical targets
Libby, P., & Aikawa, M. (2002) · Nature Medicine · doi:10.1038/nm1102-1257 · Cited by 580
Self-citationPleiotropic Effects of Statins - Basic Research and Clinical Perspectives -
Zhou, Q., & Liao, J. K. (2010) · Circulation Journal · doi:10.1253/circj.cj-10-0110 · Cited by 567
RAGE Blockade Stabilizes Established Atherosclerosis in Diabetic Apolipoprotein E–Null Mice
Bucciarelli, L. G., Wendt, T., Qu, W., Lu, Y., Lalla, E., Rong, L. L., Goova, M. T., Moser, B., Kislinger, T., Lee, D. C., et al. (2002) · Circulation · doi:10.1161/01.cir.0000039325.03698.36 · Cited by 563
Mechanisms of plaque vulnerability and rupture
Shah, P. K. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02834-6 · Cited by 541
Statin effects beyond lipid lowering—are they clinically relevant?
Bonetti, P. (2003) · European Heart Journal · doi:10.1016/s0195-668x(02)00419-0 · Cited by 527
Inflammation and Atherosclerosis: Novel Insights Into Plaque Formation and Destabilization
Stoll, G., & Bendszus, M. (2006) · Stroke · doi:10.1161/01.str.0000226901.34927.10 · Cited by 503
Inflammation, Immunity, and HMG-CoA Reductase Inhibitors: Statins as Antiinflammatory Agents?
Schönbeck, U., & Libby, P. (2004) · Circulation · doi:10.1161/01.cir.0000129505.34151.23 · Cited by 498
Self-citationNewby, A. C. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.173898 · Cited by 496
Corti, R., Fuster, V., Fayad, Z. A., Worthley, S. G., Helft, G., Smith, D., Weinberger, J., Wentzel, J., Mizsei, G., Mercuri, M., et al. (2002) · Circulation · doi:10.1161/01.cir.0000041255.88750.f0 · Cited by 470
Molecular Biology of Atherosclerosis
Hopkins, P. N. (2013) · Physiological Reviews · doi:10.1152/physrev.00004.2012 · Cited by 459
Pharmacological Actions of Statins: A Critical Appraisal in the Management of Cancer
Gazzerro, P., Proto, M. C., Gangemi, G., Malfitano, A. M., Ciaglia, E., Pisanti, S., Santoro, A., Laezza, C., & Bifulco, M. (2012) · Pharmacological Reviews · doi:10.1124/pr.111.004994 · Cited by 457
New insights into the mechanisms of venous thrombosis
Mackman, N. (2012) · Journal of Clinical Investigation · doi:10.1172/jci60229 · Cited by 436
Inflammation in Atherosclerosis: Visualizing Matrix Metalloproteinase Action in Macrophages In Vivo
Deguchi, J.-O., Aikawa, M., Tung, C.-H., Aikawa, E., Kim, D.-E., Ntziachristos, V., Weissleder, R., & Libby, P. (2006) · Circulation · doi:10.1161/circulationaha.106.619056 · Cited by 419
Self-citationRidker, P. M., Rifai, N., & Lowenthal, S. P. (2001) · Circulation · doi:10.1161/01.cir.103.9.1191 · Cited by 415
Node, K., Fujita, M., Kitakaze, M., Hori, M., & Liao, J. K. (2003) · Circulation · doi:10.1161/01.cir.0000084539.58092.de · Cited by 414
Sugiyama, S., Kugiyama, K., Aikawa, M., Nakamura, S., Ogawa, H., & Libby, P. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000131784.50633.4f · Cited by 414
Self-citationSoppert, J., Lehrke, M., Marx, N., Jankowski, J., & Noels, H. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.07.019 · Cited by 407
Kinlay, S., Schwartz, G. G., Olsson, A. G., Rifai, N., Leslie, S. J., Sasiela, W. J., Szarek, M., Libby, P., & Ganz, P. (2003) · Circulation · doi:10.1161/01.cir.0000091404.09558.af · Cited by 405
Self-citationFukumoto, Y., Libby, P., Rabkin, E., Hill, C. C., Enomoto, M., Hirouchi, Y., Shiomi, M., & Aikawa, M. (2001) · Circulation · doi:10.1161/01.cir.103.7.993 · Cited by 384
Self-citationAtherosclerotic Plaque Healing
Vergallo, R., & Crea, F. (2020) · New England Journal of Medicine · doi:10.1056/nejmra2000317 · Cited by 379
Antagonism of RANTES Receptors Reduces Atherosclerotic Plaque Formation in Mice
Veillard, N. R., Kwak, B., Pelli, G., Mulhaupt, F., James, R. W., Proudfoot, A. E. I., & Mach, F. (2004) · Circulation Research · doi:10.1161/01.res.0000109793.17591.4e · Cited by 377
Isoprenoids as mediators of the biological effects of statins
Liao, J. K. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0216421 · Cited by 352
Anti-inflammatory and immunomodulatory effects of statins
Blanco-Colio, L. M., Tuñón, J., Martín-Ventura, J. L., & Egido, J. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00744.x · Cited by 347
Luan, Z., Chase, A. J., & Newby, A. C. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000068646.76823.ae · Cited by 341
Macrophage roles following myocardial infarction
Lambert, J. M., Lopez, E. F., & Lindsey, M. L. (2008) · International Journal of Cardiology · doi:10.1016/j.ijcard.2008.04.059 · Cited by 339
Eto, M., Kozai, T., Cosentino, F., Joch, H., & Lüscher, T. F. (2002) · Circulation · doi:10.1161/01.cir.0000015465.73933.3b · Cited by 330
Ferrier, K. E., Muhlmann, M. H., Baguet, J.-P., Cameron, J. D., Jennings, G. L., Dart, A. M., & Kingwell, B. A. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01717-5 · Cited by 317
Anti-inflammatory therapeutics for the treatment of atherosclerosis
Charo, I. F., & Taub, R. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3444 · Cited by 306
Liao, J. K. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.06.009 · Cited by 304
Statins and Cardiovascular Diseases: From Cholesterol Lowering to Pleiotropy
Zhou, Q., & Liao, J. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209787315684 · Cited by 294
PARP9 and PARP14 cross-regulate macrophage activation via STAT1 ADP-ribosylation
Iwata, H., Goettsch, C., Sharma, A., Ricchiuto, P., Goh, W. W. B., Halu, A., Yamada, I., Yoshida, H., Hara, T., Wei, M., et al. (2016) · Nature Communications · doi:10.1038/ncomms12849 · Cited by 287
Self-citationUndas, A., Brummel-Ziedins, K. E., & Mann, K. G. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000151647.14923.ec · Cited by 275
Statins are Associated with a Reduced Infrarenal Abdominal Aortic Aneurysm Growth
Schouten, O., van Laanen, J. H. H., Boersma, E., Vidakovic, R., Feringa, H. H. H., Dunkelgrün, M., Bax, J. J., Koning, J., van Urk, H., & Poldermans, D. (2006) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2005.12.024 · Cited by 261
Corti, R., Worthley, S. G., Helft, G., Viles-Gonzalez, J. F., Badimon, J. J., Corti, R., Fuster, V., Fayad, Z. A., Worthley, S. G., Helft, G., et al. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.03.054 · Cited by 257
“This hypothesis is supported by several experiental and observational studies showing lipid depletion in therosclerotic lesions after prolonged lipid lowering either y statin or by diet (1,9,12,19).”
BackgroundResultStatins Exert Endothelial Atheroprotective Effects via the KLF2 Transcription Factor
Parmar, K. M., Nambudiri, V., Dai, G., Larman, H. B., Gimbrone, M. A., & García-Cardeña, G. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.c500144200 · Cited by 253
Metalloproteinases and Vulnerable Atherosclerotic Plaques
Newby, A. C. (2007) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2007.09.001 · Cited by 253
Katsuki, S., Matoba, T., Nakashiro, S., Sato, K., Koga, J.-I., Nakano, K., Nakano, Y., Egusa, S., Sunagawa, K., & Egashira, K. (2014) · Circulation · doi:10.1161/circulationaha.113.002870 · Cited by 179
Morishige, K., Kacher, D. F., Libby, P., Josephson, L., Ganz, P., Weissleder, R., & Aikawa, M. (2010) · Circulation · doi:10.1161/circulationaha.109.891804 · Cited by 168
Self-citationSubstrate elasticity regulates the behavior of human monocyte-derived macrophages
Adlerz, K. M., Aranda-Espinoza, H., & Hayenga, H. N. (2016) · European Biophysics Journal · doi:10.1007/s00249-015-1096-8 · Cited by 135
Molecular Imaging of Matrix Metalloproteinase in Atherosclerotic Lesions
Fujimoto, S., Hartung, D., Ohshima, S., Edwards, D. S., Zhou, J., Yalamanchili, P., Azure, M., Fujimoto, A., Isobe, S., Matsumoto, Y., et al. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.08.048 · Cited by 133
Inflammation and cortisol response in coronary artery disease
Nijm, J., & Jonasson, L. (2009) · Annals of Medicine · doi:10.1080/07853890802508934 · Cited by 128
Collagenases and cracks in the plaque
Libby, P. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67526 · Cited by 108
Self-citationThe Immunomodulatory Effects of Statins on Macrophages
Sheridan, A., Wheeler-Jones, C. P. D., & Gage, M. C. (2022) · Immuno · doi:10.3390/immuno2020021 · Cited by 48
Metadata
- Authors
- Aikawa, M., Rabkin, E., Sugiyama, S., Voglic, S. J., Fukumoto, Y., Furukawa, Y., Shiomi, M., Schoen, F. J., & Libby, P.
- Venue
- Circulation
- Published
- 2001-01-16
- Volume
- 103
- Issue
- 2
- Pages
- 276-283
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2112098540
- Cited by
- 588
- References
- 38
- FWCI
- 17.96
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.